Laurent P., Dussarat GV, Bonal J., et al. Low-molecular weight heparins: a guide to their optimum use in pregnancy. Drugs. 2002;62:463-477.
2.
Ginsberg JS, Greer I., Hirsh J.Use of antithrombotic agents during pregnancy. Chest. 2001;119:122S-131S.
3.
Forestier F. , Daffos F., Rainaut M., et al. Low-molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy [abstract] . Thromb Haemost.1987;57:234.
4.
Crowther MA, Spitzer K., Julian J., et al. Pharmacokinetic profile of a low-molecular weight (Reviparin) in pregnant patients: a prospective cohort study. Thromb Res.2000; 98:133-138.
5.
Yin ET, Wessler S., Butler JVPlasma heparin: a unique, practical, submicrogram-sensitive assay. J Lab Clin Med.1973;81:298-397.
